Dr. Reddy's rolls out drug-free non-invasive migraine management device ‘Nerivio’ in India
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Subscribe To Our Newsletter & Stay Updated